Trupanion (NASDAQ:TRUP) Releases Earnings Results, Beats Expectations By $0.09 EPS

Trupanion (NASDAQ:TRUP) posted its quarterly earnings results on Wednesday. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09, Briefing.com reports. The firm had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.10) earnings per share. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.

Trupanion Trading Up 3.5 %

Shares of NASDAQ:TRUP traded up $1.87 during midday trading on Wednesday, reaching $55.12. The company’s stock had a trading volume of 771,558 shares, compared to its average volume of 680,043. The firm has a market cap of $2.32 billion, a price-to-earnings ratio of -86.13 and a beta of 1.73. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a 1 year low of $19.14 and a 1 year high of $55.74. The business has a 50 day moving average price of $46.54 and a 200 day moving average price of $35.74.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Northland Securities lifted their price objective on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a report on Thursday, September 19th. Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. William Blair assumed coverage on Trupanion in a report on Friday, July 19th. They set an “outperform” rating for the company. Finally, Bank of America lifted their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $41.83.

Insider Activity

In other news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock valued at $405,238 over the last quarter. Company insiders own 5.50% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.